These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6837861)

  • 1. Elevated plasma levels of vasoactive intestinal polypeptide in short bowel syndrome.
    Lezoche E; Carlei F; Vagni V; Mora GV; Speranza V
    Am J Surg; 1983 Mar; 145(3):369-70. PubMed ID: 6837861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in plasma levels of vasoactive intestinal polypeptide in short bowel syndrome: experimental study.
    Martin Del Olmo JC; Carbajo Caballero MA; Blanco Alvarez JI; Audivert Mena L; Vaquero Puerta C
    Int Surg; 1998; 83(2):150-3. PubMed ID: 9851334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
    Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of gut hormones with irritable bowel syndrome.
    Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
    Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia.
    Modlin IM; Bloom SR; Mitchell S
    Experientia; 1978 Apr; 34(4):535-6. PubMed ID: 639959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man.
    Burhol PG; Waldum HL; Jorde R; Lygren I
    Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoative intestinal peptide and the watery diarrhea syndrome.
    Ebeid AM; Murray PD; Fischer JE
    Ann Surg; 1978 Apr; 187(4):411-6. PubMed ID: 148246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations.
    Hossdorf T; Burger M; Burger M; Karoff C; van Husen N; Wagner H
    Hepatogastroenterology; 1982 Aug; 29(4):146-50. PubMed ID: 7129338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
    Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
    Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal polypeptide (VIP) concentration after small bowel resection.
    Lezoche E
    Gastroenterology; 1978 May; 74(5 Pt 1):966. PubMed ID: 640355
    [No Abstract]   [Full Text] [Related]  

  • 11. Gut hormones in acute diarrhoea.
    Besterman HS; Christofides ND; Welsby PD; Adrian TE; Sarson DL; Bloom SR
    Gut; 1983 Jul; 24(7):665-71. PubMed ID: 6345284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
    Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
    Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human gut hormone profiles in patients with short bowel syndrome.
    Andrews NJ; Irving MH
    Dig Dis Sci; 1992 May; 37(5):729-32. PubMed ID: 1563315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
    Fahrenkrug J; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma.
    Galbo H; Hilsted J; Fahrenkrug J; Schaffalitzky De Muckadell OB
    Acta Physiol Scand; 1979 Mar; 105(3):374-7. PubMed ID: 443066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basal concentration of Substance P (SP) and Vasoactive Intestinal Peptide (VIP) in the blood serum of children with allergic dermatitis].
    Grzybowska-Chłebowczyk U; Woś H; Szymańska M; Kajor M
    Med Wieku Rozwoj; 2003; 7(1):43-8. PubMed ID: 13130168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
    Said SI
    World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea.
    Koch TR; Michener SR; Go VL
    Gastroenterology; 1991 Jan; 100(1):99-106. PubMed ID: 1983854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
    Fahrenkrug J; Schaffalitzky de Muckadell OV
    J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of vasoactive intestinal peptide in the dumping syndrome.
    Sagor GR; Bryant MG; Ghatei MA; Kirk RM; Bloom SR
    Br Med J (Clin Res Ed); 1981 Feb; 282(6263):507-10. PubMed ID: 6780101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.